The AI & Digitalisation Zone will be hosted in the exhibition area and will serve as the central hub for AI-driven drug discovery, digital R&D, and next-generation platform technologies, bringing together innovators such as Recursion, Insitro, QT Sense, and other leaders across AI discovery platforms, cloud infrastructure, automation, bioinformatics, digital biology, academic hubs, and strategic pharma tech partners. This interactive space will feature poster presentations, live demos, and short tech talks, alongside an AI Networking Lounge and a coffee cart to foster meaningful connections and collaboration. 

Join fellow industry leaders for an exclusive VIP networking dinner designed to foster meaningful connections and conversations across the drug discovery, formulation, and delivery community. Limited seating available.

Bringing together leaders from drug discovery, formulation, and drug delivery, these interactive roundtables are designed to break down traditional silos and foster cross-functional collaboration. Through open discussion and peer-to-peer exchange, participants will explore how earlier alignment across target discovery, molecule design, developability, and delivery can improve decision-making, reduce risk, and ultimately accelerate the development of successful medicines:

•  AI & In Silico Tools In Formulation Development
Moderated by Pin-Kuang Lai, Assistant Professor, Stevens Institute of Technology;

•  From Oral To Inhaled: Lifecycle Delivery Strategies For Pulmonary Disease Therapeutics
Moderated by Gian Luca Araldi, Founder & Chief Executive Officer, Avanti Biosciences

•  Dealing With High Manufacturing And Product Costs In The Gene Therapy Space
Moderated by Pranav Mathur, Director & Head Of Research & Development, Cirsium Biosciences;

•  Programming Skeletal Muscle As A Bioreactor – Building The Next Generation Of DNA-Encoded Medicines
Moderated by Marek Drozdz, Director of Research, RenBio

Our 'Women in Drug Discovery & Development' panel discussion brings together leaders and rising talent to explore career progression, leadership, and the evolving role of women across the drug discovery and development landscape. Through open discussion, the session will examine strategies for overcoming barriers, fostering mentorship and sponsorship, and driving greater diversity and influence in scientific innovation and decision-making.

Closed-door sessions offer an exclusive space for candid, off-the-record discussions. Connect with peers, share insights, and tackle the industry’s toughest challenges. Designed for executives shaping the future of the sector:

•  The Power Of Partnerships: Aligning Pharma, Biotech, And Academia To Accelerate Development & Innovation
Moderated by Denise Steckel, Head of Clinical Collaborations Development, Genentech

•  From Innovation to Impact: Market Strategies Driving the Next Wave of Drug Delivery Technologies
Featuring Eli Lilly & ValiRx

•  Delivering Therapies Across The Blood-Brain Barrier
Moderated by Zhihong Huang, Director, Novartis